Genitourinary/Renal

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
CA018005A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in
Participants with Advanced Renal Cell Carcinoma
Hotte, Dr Sebastien OpenNCT02996110
D081DC00007A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment with a New Hormonal Agent and Have Homologous Recombination Repair Gene Mutations (PROfound, D081DC00007)Hotte, Dr Sebastien OpenNCT02987543
NRG-GU003A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED POST-PROSTATECTOMY RADIATION THERAPY (HYPORT) VERSUS CONVENTIONAL POST-PROSTATECTOMY RADIATION THERAPY (COPORT)Tsakiridis, Dr TheosOpenNCT03274687
OCOG-2013-PETMUSEImpact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder StagingMukherjee, Dr SomOpenNCT02462239
OCOG-2016-MISTERAssessment of New Molecular Imaging Strategies for Prostate Cancer: Predictive Value of Established and Novel PET Radiotracers in Castration-Resistant Prostate CancerHotte, Dr Sebastien OpenNCT02813226
OZM-053A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Renal Cell Cancer Patients Receiving 1st Line Sunitinib TherapySwaminath, Dr AnandOpenNCT02019576
Prostate HBINon-Targeted Low Dose Radiotherapy For Recurrent Prostate CancerDayes, Dr IanOpenNCT03196778
WO30070A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PARTIAL -BLIND STUDY OF ATEZOLIZUMAB (ANTI-PDL1 ANTIBODY) MONOTHERAPY AND IN COMBINATION WITH PLATIMUN BASED THERAPY VERSUS PLATINUM BASED THERAPY PLUS PLACEBO IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMAMukherjee, Dr SomOpenNCT02807636
IND.223A Phase II Study of Palbociclib, A CDK4/6 Inhibitor, in Patients with Metastatic Castration-Resistant Prostate CancerMukherjee, Dr SomOn holdNCT02905318
IND.232A Phase II Study of Durvalumab With or Without Tremelimumab in Patients With Metastatic castration Resistant Prostate CancerHotte, Dr Sebastien On holdNCT02788773
PCS 9The Role of Stereotactic Body Radiotherapy in the Management of Castration-Resistant Prostate Cancer with Oligometastases: An Adaptive Phase II/III Randomized Trial.Tsakiridis, Dr TheosOn holdNCT02685397
AGS-16C3F-15-3A Multi-center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell CarcinomaHotte, Dr Sebastien On holdNCT02639182
CO39303A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL TESTING IPATASERTIB PLUS ABIRATERONE PLUS PREDNISONE/PREDNISOLONE, RELATIVE TO PLACEBO PLUS ABIRATERONE PLUS PREDNISONE/PREDNISOLONE IN ADULT MALE PATIENTS WITH ASYMPTOMATIC OR MILDLY SYMPTOMATIC, PREVIOUSLY UNTREATED, METASTATIC CASTRATE-RESISTANT PROSTATE CANCER Mukherjee, Dr SomOn holdNCT03072238
D933IC00003A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Cisplatin-Ineligible Patients With Unresectable Stage IV Urothelial CancerMukherjee, Dr SomOn holdNCT03459846
TOPCOPTOward Personalizing Care for Older men with mCRPC - understanding and predicting treatment toxicities (the TOPCOP study)Hotte, Dr Sebastien On holdNCT02512185
TRITON2A Multicenter, Open-label Phase 2 Study of Rucaparib in
Patients with Metastatic Castration-resistant Prostate Cancer Associated
with Homologous Recombination Deficiency
Hotte, Dr Sebastien On holdNCT02952534
Download PDF